GC Wealth Management RIA LLC Cuts Stock Position in Colgate-Palmolive Company $CL

GC Wealth Management RIA LLC cut its position in Colgate-Palmolive Company (NYSE:CL) by 72.7% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,860 shares of the company’s stock after selling 7,612 shares during the quarter. GC Wealth Management RIA LLC’s holdings in Colgate-Palmolive were worth $226,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the company. ProShare Advisors LLC increased its stake in shares of Colgate-Palmolive by 11.0% in the 3rd quarter. ProShare Advisors LLC now owns 2,047,542 shares of the company’s stock valued at $163,681,000 after buying an additional 202,379 shares during the period. Providence Capital Advisors LLC acquired a new position in shares of Colgate-Palmolive during the third quarter valued at $5,373,000. Asset Management One Co. Ltd. boosted its holdings in Colgate-Palmolive by 3.9% in the third quarter. Asset Management One Co. Ltd. now owns 422,292 shares of the company’s stock valued at $33,758,000 after acquiring an additional 16,017 shares during the last quarter. Citigroup Inc. boosted its holdings in Colgate-Palmolive by 43.7% in the third quarter. Citigroup Inc. now owns 1,346,590 shares of the company’s stock valued at $107,646,000 after acquiring an additional 409,710 shares during the last quarter. Finally, TD Waterhouse Canada Inc. increased its position in Colgate-Palmolive by 248.5% in the third quarter. TD Waterhouse Canada Inc. now owns 87,410 shares of the company’s stock worth $6,909,000 after purchasing an additional 62,327 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive News Roundup

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Q1 top‑ and bottom‑line beat — Colgate reported EPS of $0.97 vs. $0.95 consensus and revenue of $5.32B (up 8.4% YoY), driven by pricing and volume growth; organic sales rose and base business EPS increased. Colgate Q1 Earnings & Sales Beat Estimates on Pricing & Volume Growth
• Positive Sentiment: Strong international demand for core oral and personal care boosted results and topline momentum, a cited driver behind the beat. Colgate‑Palmolive beats Q1 estimates on strong international demand
• Positive Sentiment: Board expands strategic growth & restructuring program — management is accelerating a multi‑year program (approved July 2025) intended to drive growth and cost savings, which supports margin recovery expectations. Colgate‑Palmolive Expands Strategic Growth and Restructuring Program
• Neutral Sentiment: Management commentary and slides — the earnings call and slide deck provide detail on region‑level trends, pricing versus volume dynamics, and the timing of savings from the restructuring program. Review the transcript/slides for forward commentary. Colgate‑Palmolive Q1 2026 Earnings Call Transcript
• Neutral Sentiment: Analysts updated forecasts ahead of and after the print — some revisions were already in place heading into the quarter; keep an eye on any further changes to price targets or model assumptions. Colgate‑Palmolive Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
• Negative Sentiment: Margin pressure and one‑time/SGPP charges — GAAP EPS fell YoY (to $0.80) and gross profit margin slipped ~20 bps; management flagged costs and restructuring/SGPP charges that weighed on margins this quarter. These items are a watch point for near‑term profitability until savings materialize. Colgate Announces 1st Quarter 2026 Results

Colgate-Palmolive Stock Up 2.1%

Colgate-Palmolive stock opened at $87.15 on Friday. The company has a 50 day moving average of $87.95 and a 200-day moving average of $84.11. The company has a quick ratio of 0.54, a current ratio of 0.83 and a debt-to-equity ratio of 18.82. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33. The stock has a market capitalization of $69.92 billion, a PE ratio of 33.91, a price-to-earnings-growth ratio of 4.46 and a beta of 0.31.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, May 1st. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.94 by $0.03. The business had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.22 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. During the same period in the previous year, the firm posted $0.91 EPS. The firm’s revenue was up 8.4% compared to the same quarter last year. On average, equities research analysts anticipate that Colgate-Palmolive Company will post 3.85 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Monday, April 20th will be issued a dividend of $0.53 per share. The ex-dividend date is Monday, April 20th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.4%. Colgate-Palmolive’s dividend payout ratio is 80.92%.

Insider Transactions at Colgate-Palmolive

In related news, insider Sally Massey sold 15,851 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total value of $1,506,320.53. Following the sale, the insider owned 13,751 shares of the company’s stock, valued at approximately $1,306,757.53. This trade represents a 53.55% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Panagiotis Tsourapas sold 15,000 shares of the company’s stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $97.81, for a total value of $1,467,150.00. Following the transaction, the chief operating officer directly owned 10,415 shares of the company’s stock, valued at approximately $1,018,691.15. This trade represents a 59.02% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 184,683 shares of company stock worth $17,486,693 in the last 90 days. 0.43% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several analysts have weighed in on CL shares. JPMorgan Chase & Co. dropped their price objective on Colgate-Palmolive from $97.00 to $95.00 and set an “overweight” rating for the company in a report on Friday, April 17th. Bank of America lowered their price target on shares of Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating for the company in a research report on Friday, April 10th. Citigroup boosted their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Monday, February 2nd. Morgan Stanley cut their price objective on shares of Colgate-Palmolive from $100.00 to $95.00 and set an “overweight” rating on the stock in a report on Thursday, April 23rd. Finally, UBS Group reduced their price objective on shares of Colgate-Palmolive from $100.00 to $98.00 and set a “buy” rating on the stock in a research note on Tuesday, April 7th. Twelve equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and an average price target of $95.56.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.